サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439700

ステント - 世界市場の考察、競合情勢、市場予測（2030年）

Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
ステント - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のステントの市場規模は、2024年～2030年の予測期間にCAGRで5.61％の成長が見込まれます。市場は、慢性疾患の有病率の増加、老年人口の増加、低侵襲処置の需要の増加、不健康なライフスタイルの増加などの要因によってプラス成長を示しており、これらすべての要因が2024年～2030年の予測期間におけるステント市場の成長に寄与します。

ステントの市場力学

ステント市場の主な促進要因の1つは、慢性疾患の有病率の増加です。さらに、慢性疾患の有病率の上昇は、世界の患者人口における死亡率の上昇につながります。例えば、世界保健機関（WHO）が2022年に発表したデータによると、世界では毎年4,100万人（71％）が慢性疾患が原因で死亡しています。さらに、30～69歳の死亡者数は毎年1,500万人、心血管疾患による死亡者数は毎年1,790万人、次いでがん（930万人）、呼吸器疾患（410万人）、糖尿病（150万人）と推定されています。これら4つの疾患は、慢性死亡の80％以上を占めています。糖尿病患者は冠動脈疾患、心臓発作などの心血管系疾患にかかりやすいです。さらにステントは、呼吸器疾患や心血管系疾患だけでなく、胃がん、肺がんといったがんの治療にも使用できます。したがって、これらの慢性疾患の有病率の上昇により、死亡率も大幅に増加しています。したがって、ステントによる治療を提供することで、慢性疾患の結果として増加している死亡率も最小化でき、ステント市場の需要と成長が促進されます。

世界保健機関（WHO）の2022年10月のデータによると、2015年～2050年に60歳以上の人口は12～22％から倍増し、2050年までに21億人に達すると推定されています。さらに2030年までに、世界の6人に1人が60歳以上となります。80歳以上の人口は2020年～2050年に3倍に増え、4億2,600万人に達すると予測されています。したがって、老年人口の増加は慢性疾患の増加につながります。このような老年人口は、冠動脈疾患など、治療ソリューションとしてステントの植込みを必要とする疾患にかかる可能性が高くなるため、需要が増加し、ステント市場の成長を高める可能性があります。

しかし、ステントに対する規制当局の厳格な承認や、ステント留置に伴う合併症が、ステント市場の成長を減速させる可能性があります。

さらに、進行中のCOVID-19パンデミックは、ステント市場にマイナスの影響を与えています。ほぼすべての国で全国的なロックダウンが行われたため、人の移動が制限され、サプライチェーンとロジスティクスが停止し、生産拠点で労働力を確保できないために製造率が低下し、市場で製品が不足し、COVID-19患者の治療が優先されたため、選択的手術が後回しにされています。例えば、American Hospital Association（2020）によると、2020年3月～6月に、ステント留置を含む「選択的」手術が減少した結果、米国の病院に507億米ドルの損失が生じたと推定されています。同じ資料によれば、これらの処置は平均して米国の純収益の約31％を占めていました。しかし、大衆への予防接種やロックダウン規制の緩和、サプライチェーン、ロジスティクス、製造機器の再開、選択的手術の増加により、ステント市場は勢いを取り戻し、予測期間にさらなる成長が見込まれます。

ステント市場のセグメント分析

ステント市場の製品タイプセグメントでは、冠動脈ステントが2022年にもっとも高いシェアを占めると推定されます。冠動脈の閉塞によって引き起こされる心臓発作を回避するため、閉塞した動脈を治療するためにステントが導入されます。WHOの2022年のデータによると、2019年に世界で約1,790万人が心血管疾患が原因で死亡しました。1,700万人の早死（70歳未満の人）のうち、38％が心血管疾患が原因で死亡しています。したがって、心血管疾患の有病率の増加により、死亡率も増加しています。したがって、冠動脈ステントによる治療を提供することで、これらの心血管疾患による死亡率を抑制することができ、これが冠動脈ステント市場の成長を引き起こし、2024年～2030年におけるステント市場全体の成長につながります。

当レポートでは、世界のステント市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 ステント市場レポートのイントロダクション

第2章 ステント市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 ステント市場の主な要因の分析

  • ステント市場の促進要因
    • 慢性疾患の有病率の増加
    • 老年人口の増加
    • ステントに関連する技術の進歩
    • 座りがちな生活習慣の蔓延
  • ステント市場の抑制要因と課題
    • ステントに対する規制当局の厳格な承認
    • ステントの植込みに伴う合併症
  • ステント市場の機会
    • 薬物溶出ステントの需要の高まり
    • ステント開発における3Dプリンティングの進歩

第5章 ステント市場のポーターのファイブフォース分析

第6章 ステント市場に対するCOVID-19の影響分析

第7章 ステント市場のレイアウト

  • 製品タイプ別
    • 冠動脈
    • 静脈
    • 胆道
    • 末梢血管
    • その他
  • 材料タイプ別
    • ポリマー
    • 合金
    • 金属
  • タイプ別
    • 自己拡張型ステント
    • バルーン拡張型ステント
  • エンドユーザータイプ別
    • 病院
    • 外来手術センター
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 ステント市場：世界の企業シェア分析 - 主要3～5社

第9章 ステント市場の企業と製品のプロファイル

  • Boston Scientific Corporation
  • BD
  • Medtronic
  • Abbott
  • Cook
  • Merit Medical Systems
  • Novatech SA
  • Terumo Europe NV
  • MicroPort Scientific Corporation
  • Fuji Systems Corp
  • MICRO-TECH EUROPE
  • Vascular Concepts
  • Olympus America
  • W. L. Gore & Associates Inc
  • B. Braun Melsungen AG
  • BIOTRONIK SE & Co. KG
  • Teleflex Incorporated
  • Elixir Medical Corporation
  • REVA Medical, LLC

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Stents Market in Global (2021-2030)
  • Table 4: Stents Market in Global by Product Type (2021-2030)
  • Table 5: Stents Market in Global by Material Type (2021-2030)
  • Table 6: Stents Market in Global by Type (2021-2030)
  • Table 7: Stents Market in Global by End User (2021-2030)
  • Table 8: Stents Market in Global by Geography (2021-2030)
  • Table 9: Stents Market in North America (2021-2030)
  • Table 10: Stents Market in North America by Country (2021-2030)
  • Table 11: Stents Market in the US (2021-2030)
  • Table 12: Stents Market in Canada (2021-2030)
  • Table 13: Stents Market in Mexico (2021-2030)
  • Table 14: Stents Market in Europe (2021-2030)
  • Table 15: Stents Market in Europe by Country (2021-2030)
  • Table 16: Stents Market in France (2021-2030)
  • Table 17: Stents Market in Germany (2021-2030)
  • Table 18: Stents Market in the United Kingdom (2021-2030)
  • Table 19: Stents Market in Italy (2021-2030)
  • Table 20: Stents Market in Spain (2021-2030)
  • Table 21: Stents Market in Russia (2021-2030)
  • Table 22: Stents Market in Rest of Europe (2021-2030)
  • Table 23: Stents Market in APAC (2021-2030)
  • Table 24: Stents Market in APAC by Country (2021-2030)
  • Table 25: Stents Market in China (2021-2030)
  • Table 26: Stents Market in Japan (2021-2030)
  • Table 27: Stents Market in India (2021-2030)
  • Table 28: Stents Market in Australia (2021-2030)
  • Table 29: Stents Market in South Korea (2021-2030)
  • Table 30: Stents Market in Rest of APAC (2021-2030)
  • Table 31: Stents Market in Rest of World (2021-2030)
  • Table 32: Stents Market in RoW by Region (2021-2030)
  • Table 33: Stents Market in Middle East (2021-2030)
  • Table 34: Stents Market in Africa (2021-2030)
  • Table 35: Stents Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Stents Market in Global (2021-2030)
  • Figure 4: Stents Market in Global by Product Type (2021-2030)
  • Figure 5: Stents Market in Global by Material Type (2021-2030)
  • Figure 6: Stents Market in Global by Type (2021-2030)
  • Figure 7: Stents Market in Global by End User (2021-2030)
  • Figure 8: Stents Market in Global by Geography (2021-2030)
  • Figure 9: Stents Market in North America (2021-2030)
  • Figure 10: Stents Market in North America by Country (2021-2030)
  • Figure 11: Stents Market in the US (2021-2030)
  • Figure 12: Stents Market in Canada (2021-2030)
  • Figure 13: Stents Market in Mexico (2021-2030)
  • Figure 14: Stents Market in Europe (2021-2030)
  • Figure 15: Stents Market in Europe by Country (2021-2030)
  • Figure 16: Stents Market in France (2021-2030)
  • Figure 17: Stents Market in Germany (2021-2030)
  • Figure 18: Stents Market in the United Kingdom (2021-2030)
  • Figure 19: Stents Market in Italy (2021-2030)
  • Figure 20: Stents Market in Spain (2021-2030)
  • Figure 21: Stents Market in Russia (2021-2030)
  • Figure 22: Stents Market in Rest of Europe (2021-2030)
  • Figure 23: Stents Market in APAC (2021-2030)
  • Figure 24: Stents Market in APAC by Country (2021-2030)
  • Figure 25: Stents Market in China (2021-2030)
  • Figure 26: Stents Market in Japan (2021-2030)
  • Figure 27: Stents Market in India (2021-2030)
  • Figure 28: Stents Market in Australia (2021-2030)
  • Figure 29: Stents Market in South Korea (2021-2030)
  • Figure 30: Stents Market in Rest of APAC (2021-2030)
  • Figure 31: Stents Market in Rest of World (2021-2030)
  • Figure 32: Stents Market in RoW by Region (2021-2030)
  • Figure 33: Stents Market in Middle East (2021-2030)
  • Figure 34: Stents Market in Africa (2021-2030)
  • Figure 35: Stents Market in South America (2021-2030)
  • Figure 36: Market Drivers
  • Figure 37: Market Barriers
  • Figure 38: Marker Opportunities
  • Figure 38: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0542

Stents Market By Product Type (Coronary, Venous, Biliary, Peripheral And Others), By Material Type (Polymer, Alloy And Metal), By Type (Self-Expanding And Balloon-Expandable Stents), By End-User Type (Hospitals And Ambulatory Surgical Centers, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing prevalence of chronic diseases and rise in geriatric population.

Global stents market is estimated to grow at a CAGR of 5.61% during the forecast period from 2024 to 2030. The stents market is witnessing a positive growth owing to the factors such as increasing prevalence of chronic diseases, rise in geriatric population, increasing demand of minimally invasive procedures, increase in unhealthy lifestyle, thereby all factors contributing to the growth of stents market during the forecast period from 2024-2030.

Stents Market Dynamics:

One of the main drivers of the stents market is the increasing prevalence of chronic diseases. Furthermore, the rise in the prevalence of chronic diseases will lead to an increase in the mortality rate among the patient population globally. For instance, according to the dada published by World Health Organization (WHO) in 2022, each year 41 million or 71% deaths globally takes place due to chronic diseases. Further, it is estimated that 15 million people aged 30-69 years die each year, 17.9 million die due to cardiovascular diseases annually, followed by cancer (9.3 million), respiratory diseases (4.1 million), and diabetes (1.5 million). All these four diseases account for over 80% of all chronic deaths. People living with diabetes are more prone to cardiovascular diseases such as coronary artery disease, heart attack, and others. Moreover, stents can be used to treat cancers such as stomach, lung and others as well as respiratory and cardiovascular diseases. Therefore, owing to a rise in the prevalence of these chronic diseases, the death rate is also increasing significantly. Thus, by providing the treatment with the help of stents, the mortality rate that is increasing as a result of chronic diseases can also be minimized, thereby driving the demand and growth of stents market.

Moreover, another key factor which is responsible for the growth of stents market is rise in geriatric population, according to World Health Organization (WHO) October 2022 data, it was estimated that between year 2015-2050 people of age 60 and above will be doubled from 12-22% and will reach 2.1 billion by 2050. Further, by 2030, 1 in 6 people in the world will age 60 years or above. The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. Therefore, rise in geriatric population will lead to rise in chronic diseases as this population have more chances of getting diseases such as coronary artery diseases and others which require implantation of stents as their treatment solution, which can enhance the growth of stents market as the demand will rise.

However, stringent regulatory approvals for stents and complications associated with implantation of stents can slow down the stents market growth.

Additionally, the ongoing COVID-19 pandemic has negatively impacted the stents market. The nationwide lockdown in almost every country, restricted the movement of people, supply chains & logistics were halted, unavailability of the workforce at the production sites hampered the manufacturing rate due to which there was product shortage in the market, elective surgeries were not given priority as COVID-19 patients were given more preference in terms of treatment. For instance, as per the American Hospital Association 2020, in between March and June 2020, there had been an estimated loss of USD 50.7 billion to the United States hospitals as a result of the reduction observed in "elective" procedures including stents implantation. As per the same source, on an average these procedures had accounted to about 31% of the net revenue in the United States. However, with masses being vaccinated, relaxation in lockdown restrictions, resumption of supply chains, logistics, and manufacturing units, increase in the elective surgeries, the stents market has picked momentum and is expected to further grow during the forecast period.

Stents Market Segment Analysis:

Stents market by Product Type (Coronary, Venous, Biliary and Peripheral, Others), by Material Type (Polymer, Alloy and Metal ), by Type (Self-Expanding and Balloon-Expandable Stents), by End-User Type (Hospitals, Ambulatory Surgical Centers, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In by product type segment of stents market, coronary stents are estimated to hold highest share in year 2022, to avoid the heart attack which is caused due to blockage of coronary arteries, stents can be introduced to treat blocked arteries. According to WHO 2022 data, in 2019 approximately 17.9 million people died due to cardiovascular diseases globally. Out of 17 million premature death (people of age under 70), 38% deaths were caused due to cardiovascular diseases. Therefore, due to increasing prevalence of cardiovascular diseases, death rate is also increasing. Thus, providing treatment with the help of coronary stents, mortality rate due to these cardiovascular diseases can be limited, this induces the growth of coronary stents market leading to the growth of overall stents market forcast during (2024-2030).

The rising approval and launch of coronary stent will alos promote the demand of stents, leading to an overall growth of the stents market, for instance, in September 2022, BIOTRONIK, a leading medical device company, announced U.S. Food and Drug Administration (FDA) approval of its Orsiro® mission bioabsorbable polymer coronary drug-eluting stent system (BP-DES) in the US.

Therefore, increasing prevalence of cardiovascular diseases and approval & launch of coronary stents, increases the stents demand thereby, driving the growth of the overall stents market during the forecast period from 2024-2030.

North America is expected to dominate the overall Stents Market:

Among all the regions, North America is estimated to dominate the global stents market in the year 2023 and is expected to do the same during the forecast period from 2024-2030. Factors such as rising prevalence of sedentary lifestyle and rising technological advancements associated with the stents increases the stents market in North America.

According to Centers For Disease Control and Prevention (CDC) January 2022 data, in 2022, 25% of the US adults population were found to be physically inactive. In 2020, more then 15% adults were physically inactive. Therefore, rising prevalence of sedentary lifestyle enhance the risk of developing diseases such as diabetes, cancer and others among the US population which require stents as a treatment solution ultimately increase the demand of stents thereby, propelling the growth of stents market in North America.

Furthermore, technological advancements also driving the growth of stents market. For instance, in August 2019, FDA approved treatment of peripheral arterial disease with paclitaxel-coated balloons and paclitaxel-eluting stents are approved to treat obstructed lesions in arteries of the legs.

Further, in January 2020, FDA Approved 3D-printed airway stents developed by Cleveland Clinic doctor, these stents are used to keep the airways open of patients having serious disorders, such as tumors, inflammation, trauma or other masses.

Thus, all above mentioned factors wil surge the demand of stents thereby, driving the growth of the overall stents market during the forecast period from 2024-2030.

Stents Market Key Players:

Some of the key market players operating in the stents market include Boston Scientific Corporation, BD, Medtronic, Abbott, Cook, Merit Medical Systems, Novatech SA, Terumo Europe NV, MicroPort Scientific Corporation, Fuji Systems Corp, MICRO-TECH EUROPE, Vascular Concepts, Olympus America, W. L. Gore & Associates, Inc, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Teleflex Incorporated, Elixir Medical Corporation, REVA Medical, LLC, among others.

Recent Developmental Activities in the Stents Market:

In June 2022, Abbott, a global healthcare leader announced its XIENCE family of stents has received FDA approval for one-month DAPT labeling for high bleeding risk (HBR) patients in the U.S

In October 2020, Medtronic plc, a global leader in medical technology, announced that it has received FDA approval for the Abre(TM) venous self-expanding stent system in U.S for use in the iliofemoral veins in patients with symptomatic iliofemoral venous outflow obstruction

In March 2019, BD, a leading global medical technology company, received U.S. FDA premarket approval for first venous stent to treat iliofemoral venous occlusive disease

Key Takeaways from the Stents Market Report Study:

  • Market size analysis for current stents market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the stents.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
  • Key companies dominating the global stents.
  • Various opportunities available for the other competitor in the stents market space.
  • What are the top performing segments in 2023? How these segments will perform in 2030.
  • Which is the top-performing regions and countries in the current stents market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for stents market growth in the coming future?

Target Audience who can be benefited from this Stents Market Report Study

  • Stents products providers
  • Research organizations and consulting companies
  • Stents-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in stents
  • Various End-users who want to know more about the stents market and latest technological developments in the stents

Frequently Asked Questions for Stents Market:

1. What are Stents?

Stents are tiny metal or plastic tubes which are inserted in a blocked passageway to keep it open. Depending on where it is placed stent restores the flow of blood or other fluids.

2. What is the market for Global Stents?

Global stents market is estimated to grow at a CAGR of 5.61% during the forecast period from 2024 to 2030.

3. What are the drivers for the Global Stents Market?

The stents market is witnessing a positive market growth owing to the factors such as, increasing prevalence of chronic diseases, rise in geriatric population, increasing demand of minimally invasive procedures, increase in unhealthy lifestyle, surge in sedentary lifestyle, technological advancements in product offerings.

4. Who are the key players operating in the Stents Market?

Some of the key market players operating in the stents market include Boston Scientific Corporation, BD, Medtronic, Abbott, Cook, Merit Medical Systems, Novatech SA, Terumo Europe NV, MicroPort Scientific Corporation, Fuji Systems Corp, MICRO-TECH EUROPE, Vascular Concepts, Olympus America, W. L. Gore & Associates, Inc, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Teleflex Incorporated, Elixir Medical Corporation, REVA Medical, LLC, among others.

5. Which region has the highest share in Stents Market?

North America is estimated to dominate the global stents market. Factors contributing to the growth of stents market includes rising prevalence of sedentary lifestyle, increasing product approval in the region, and rising technological advancements associated with the stents are drivgn the North America stents market.

Table of Contents

1.Stents Market Report Introduction

2.Stents Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The US
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Stents Market Key Factors Analysis

  • 4.1. Stents Market Drivers
    • 4.1.1. Increasing Prevalence of Chronic Diseases
    • 4.1.2. Rise in Geriatric Population
    • 4.1.3. Rising Technological Advancements Associated with the Stents
    • 4.1.4. Rising Prevalence of Sedentary Lifestyle
  • 4.2. Stents Market Restraints And Challenges
    • 4.2.1. Stringent Regulatory Approvals for Stents
    • 4.2.2. Complications Associated With Implantation of Stents
  • 4.3. Stents Market Opportunities
    • 4.3.1. Growing Demand of Drug-Eluting Stents
    • 4.3.2. 3D Printing Advancements in Development of Stents

5. Stents Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Stents Market

7. Stents Market Layout

  • 7.1. By Product Type
    • 7.1.1. Coronary
    • 7.1.2. Venous
    • 7.1.3. Biliary
    • 7.1.4. Peripheral
    • 7.1.5. Others
  • 7.2. By Material Type
    • 7.2.1. Polymer
    • 7.2.2. Alloy
    • 7.2.3. Metal
  • 7.3. By Type
    • 7.3.1. Self-Expanding Stents
    • 7.3.2. Balloon-Expanding Stents
  • 7.4. By End User Type
    • 7.4.1. Hospitals
    • 7.4.2. Ambulatory Surgical Centers
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. North America Stents Market, by Country
      • 7.5.1.1.1. US
      • 7.5.1.1.2. Canada
      • 7.5.1.1.3. Mexico
    • 7.5.2. Europe
      • 7.5.2.1. Europe Stents Market, by Country
      • 7.5.2.1.1. France
      • 7.5.2.1.2. Germany
      • 7.5.2.1.3. United Kingdom
      • 7.5.2.1.4. Italy
      • 7.5.2.1.5. Spain
      • 7.5.2.1.6. Russia
      • 7.5.2.1.7. Rest of Europe
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. Asia-Pacific Stents Market, by Country
      • 7.5.3.1.1. China
      • 7.5.3.1.2. Japan
      • 7.5.3.1.3. India
      • 7.5.3.1.4. Australia
      • 7.5.3.1.5. South Korea
      • 7.5.3.1.6. Rest of Asia Pacific
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. RoW Stents Market, by Region
      • 7.5.4.1.1. Middle East
      • 7.5.4.1.2. Africa
      • 7.5.4.1.3. South America

8. Stents Market Global Company Share Analysis - Key 3-5 Companies

9. Stents Market Company and Product Profiles

  • 9.1. Boston Scientific Corporation
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. BD
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Medtronic
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Abbott
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Cook
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. Merit Medical Systems
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Novatech SA
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Terumo Europe NV
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. MicroPort Scientific Corporation
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Fuji Systems Corp
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. MICRO-TECH EUROPE
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Vascular Concepts
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. Olympus America
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. W. L. Gore & Associates Inc
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. B. Braun Melsungen AG
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. BIOTRONIK SE & Co. KG
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. Teleflex Incorporated
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. Elixir Medical Corporation
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. REVA Medical, LLC,
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us